This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Octave Specialty (OSG) Soars 8.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Octave Specialty (OSG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OSGPositive Net Change PRUPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
The Oncology Institute (TOI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TOINegative Net Change CONPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Texas Roadhouse (TXRH) Soars 3.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Texas Roadhouse (TXRH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
TXRHPositive Net Change RRGBPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
BJ's Restaurants (BJRI) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
BJ's Restaurants (BJRI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BJRIPositive Net Change KRUSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Marcus (MCS) Moves 6.3% Higher: Will This Strength Last?
by Zacks Equity Research
Marcus (MCS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
MCSPositive Net Change NCLHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Citizens (CIA) Stock Jumps 7.2%: Will It Continue to Soar?
by Zacks Equity Research
Citizens (CIA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CIANegative Net Change RGAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?
by Zacks Equity Research
Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MIRMNegative Net Change NTLANegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
JNJPositive Net Change NVSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Goosehead (GSHD) Soars 6.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Goosehead (GSHD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GSHDPositive Net Change FNFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
by Zacks Equity Research
AbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ABBVPositive Net Change INVAPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today